Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

40%(2 trials)

Phase Distribution

Ph phase_2

57%

Ph phase_3

14%

Ph phase_4

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 2Efficacy & side effects

4(57.1%)

Phase 3Large-scale testing

1(14.3%)

Phase 4Post-market surveillance

2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Other(2)

Detailed Status

Completed5

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 24 (57.1%)

Phase 31 (14.3%)

Phase 42 (28.6%)

Trials by Status

completed571%

unknown229%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_2

Rituximab in Systemic Sclerosis

NCT01748084

completedphase_3

Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

NCT01436396

completedphase_2

Effects of Ketones and Niacin in Heart Failure Patients

NCT04703361

unknownphase_2

Cell Therapy in Critical Limb Ischemia

NCT03994666

unknownphase_2

Immunomodulation of EA-230 Following On-pump Coronary Artery Bypass Grafting (CABG)

NCT03145220

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT01748084Phase 2

Rituximab in Systemic Sclerosis

Completed

NCT01436396Phase 3

Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

Completed

NCT04703361Phase 2

Effects of Ketones and Niacin in Heart Failure Patients

Completed

NCT03994666Phase 2

Cell Therapy in Critical Limb Ischemia

Unknown

NCT03145220Phase 2

Immunomodulation of EA-230 Following On-pump Coronary Artery Bypass Grafting (CABG)

Unknown

NCT00977769Phase 4

Carbetocin Versus Oxytocin and Hemodynamic Effects

Completed

NCT00525551Phase 4

Efficacy of Acetylcysteine in Patients Undergoing Surgery for Otosclerosis

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7